| Pharmaceuticals Industry | Healthcare Sector | Mr. Mark B. Saldanha CEO | XNSE Exchange | INE750C01026 ISIN |
| India Country | 852 Employees | 1 Aug 2025 Last Dividend | 11 Mar 2008 Last Split | - IPO Date |
Marksans Pharma Limited is a prominent global pharmaceutical company with its roots firmly planted in the research, development, manufacturing, and marketing of generic pharmaceutical formulations. Incorporated in 1992, this company has established a significant presence in the pharmaceutical industry, extending its services worldwide with a headquarter in Mumbai, India. With a comprehensive approach towards healing and wellness, Marksans Pharma is dedicated to providing high-quality healthcare solutions across a multitude of therapeutic areas, ensuring a broad spectrum of patients benefit from their products.